Biostrand SRL
12.9 FTEBiostrand reported total assets of 804,186 € at the end of the 2026 financial year (annual accounts filed with the NBB on 01 Oct 2026), with 12.9 full-time equivalents.
The score of Biostrand shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Total assets -66 % Headcount (avg FTE) +39 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biostrand's annual accounts
Filed annual accounts
- Year ended 30 Apr 2026filed on 01 Oct 2026
- Year ended 30 Apr 2025filed on 17 Sep 2025
- Year ended 30 Apr 2024filed on 29 Nov 2024
- Year ended 30 Apr 2023filed on 20 Dec 2023
- Year ended 30 Apr 2022filed on 29 Dec 2022
Biostrand's financial analysis
- Solvency-1591.7%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biostrand
Biostrand's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0719.913.907
- VAT number
- BE0719913907
- Peppol
- Registered · 0208:0719913907 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Feb 2019
- Registered office
- 3590 Diepenbeek
- Size
- Small · 12.9 FTE
- Latest accounts
- 2026 · filed on 01 Oct 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Biostrand (SRL) has been based in Diepenbeek since 2019, active in: research and experimental development on biotechnology. For 2026, it reports a net loss of €5.06m and equity of −€12.8m; its revenue is not published. With 12.9 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at -1591.7%, below the median of its sector (61.7%).
Companies similar to Biostrand
Companies in the same business, of comparable size and area, outside its group.
- Clenio Research and experimental development on natural sciences and engineering Liège · balance sheet 884,617 €
- Protea Biopharma NV Research and experimental development on natural sciences and engineering Asse · balance sheet €1.30m
- Focus Clinical Consultancy Research and experimental development on natural sciences and engineering Bilzen-Hoeselt · balance sheet 571,822 €
- GeneriX Business and other management consultancy activities Seraing · balance sheet €1.00m
- Agroptimize Research and experimental development on natural sciences and engineering Arlon · balance sheet €2.07m
- Aneurotech Research and experimental development on natural sciences and engineering Alken · balance sheet €2.91m
- Inhatarget Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €2.16m
- Vixen Biosystems Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.19m
Frequently asked questions about Biostrand
What is the revenue of Biostrand?
Biostrand files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Biostrand?
In Belgium, the VAT number is the company number prefixed with BE: BE0719913907 for Biostrand, if the company is VAT-registered. Its company number (CBE) is 0719.913.907.
Where is the registered office of Biostrand?
According to the CBE register, the registered office of Biostrand is in 3590 Diepenbeek.
What is the equity of Biostrand?
At the close of the 2026 financial year, the equity of Biostrand amounts to -12,800,121 €, a solvency of -1591.7% of total assets.
How many people work at Biostrand?
12.9 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Biostrand?
The register lists 5 active mandates at Biostrand. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biostrand
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →